Schizophrenia / Edition 2

Paperback (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $42.53
Usually ships in 1-2 business days
(Save 53%)
Other sellers (Paperback)
  • All (3) from $42.53   
  • New (1) from $80.00   
  • Used (2) from $42.53   
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any coupons and promotions
Seller since 2014

Feedback rating:



New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

Brand new.

Ships from: acton, MA

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
Page 1 of 1
Showing All
Sort by


This new edition of the second volume in the WPA Series, Evidence and Experience in Psychiatry, focuses on the controversial issues surrounding schizophrenia. By using systematic reviews with accompanying commentaries this volume is able to assess the 'evidence' and 'experience' to give a critical and objective account of the relevant issues, while focusing on key topics, such as diagnosis and prevention of disability and stigma.

" diagnostic process, criteria, current controversies; therapeutic approaches; disability, stigma; ethics, and costs."

Read More Show Less

Product Details

Table of Contents

List of Review Contributors
Ch. 1 Diagnosis of Schizophrenia
Diagnosis of Schizophrenia: A Review
1.1 The Diagnosis of Schizophrenia: Practice and Concept
1.2 Should Schizophrenia as a Disease Entity Concept Survive into the Third Millennium?
1.3 On Defining Schizophrenia
1.4 Diagnosis and Pathophysiology of Schizophrenia
1.5 The Significance of Intuition for the Diagnosis of Schizophrenia
1.6 Heterogeneity vs. Homogeneity in Operationally-diagnosed Schizophrenia
1.7 Diagnosis of Schizophrenia: Arguments for a Narrowing of the Concept
1.8 Schizophrenia: A Provisional Diagnostic Convention
1.9 Diagnosing Schizophrenia: A Personal View
1.10 Comments on the Diagnosis of the Schizophrenic Syndrome
1.11 The Schizophrenic Syndrome: A Warning and a Conjecture
1.12 A Century of Schizophrenia is Enough
1.13 Diagnosis of Schizophrenia: A View from Developing Countries
1.14 Studies on Schizophrenic Symptomatology in Peru
1.15 Neuropsychological and Psychophysiological Contributions to the Diagnosis of Schizophrenia
Ch. 2 Pharmacological Treatment of Schizophrenia
Pharmacological Treatment of Schizophrenia: A Review
2.1 Pharmacotherapy of Psychotic Disorders: A Perspective on Current Developments
2.2 Pharmacotherapy of Schizophrenia: Gaps in our Knowledge
2.3 Atypical Antipsychotic Drugs and Schizophrenia
2.4 Compliance Issues and the New Antipsychotics
2.5 Schizophrenia and Second-generation Antipsychotics: Mechanistic Implications and Potential for Early Intervention
2.6 Dose and Duration of Antipsychotic Treatment: Key Variables, Critical Uncertainties
2.7 Dosing Problems of Classical Neuroleptics and the Relevance of Novel/Atypical Antipsychotics in the Pharmacotherapy of Schizophrenic Disorders
2.8 Can We Use Pharmacotherapy More Logically in Schizophrenia and Other Psychoses?
2.9 Long-term Treatment in Schizophrenia: For Whom and How Long?
2.10 Novel Antipsychotics in Schizophrenia and Related Disorders: Preliminary Findings from a First-episode Study
2.11 The Pharmacotherapy of Schizophrenia in Clinical Practice
2.12 A New Era of Hope in Treating Persons with Schizophrenia
2.13 New Perspectives in Antipsychotic Pharmacotherapy
2.14 Some Aspects of the Maintenance Treatment of Schizophrenia
2.15 Highlights on the Management of Schizophrenia
2.16 Pharmacotherapy of Schizophrenia: The Case of the Developing Countries
Ch. 3 Psychotherapies for Schizophrenia
Psychotherapies for Schizophrenia: A Review
3.1 Relevant Methods, Goals, Time-dimensions and Emotional Influences in the Psychotherapy of Schizophrenia
3.2 Family and Individual Cognitive-Behavioural Interventions
3.3 It is no Longer Surprising that Cognitive-Behavioural Therapy Reduces Distressing Psychotic Symptoms
3.4 Serious Questions Remain Concerning Efficacy, Effectiveness and Scope of Family Interventions in Schizophrenia
3.5 The Interaction of Psychotherapy and Drugs in the Management of Schizophrenia: A Neglected Field
3.6 How Effective are Psychotherapies for Schizophrenia?
3.7 Need for an Integrated and Need-adapted Approach in Treating Schizophrenia
3.8 To Integrate the Psychotherapy of Schizophrenia into the Activities of the Multidisciplinary Team, and to Base it on the Principles of Evolutionary Biology
3.9 Psychotherapy for Schizophrenia: An Important Addition to Medication Alone?
3.10 The Effectiveness of Cognitive-Behavioural Therapy in Schizophrenia
3.11 Family: A System Which Cannot Be Neglected
3.12 Psychological Interventions for Schizophrenia in Developing Countries
Ch. 4 Prevention of Disability and Stigma Related to Schizophrenia
Prevention of Disability and Stigma Related to Schizophrenia: A Review
4.1 What Works for the Rehabilitation of Schizophrenia? A Brief Review of the Evidence
4.2 The Stigma of Mental Illness: Some Empirical Findings
4.3 Reducing the Stigma Associated with Schizophrenia
4.4 The Influence of Stigma on Preventive Efforts in Psychotic Disorders
4.5 Disability, Stigma and Discrimination: A View from Outside the USA
4.6 The Toxic Effects to Stigma
4.7 The Conceptualization of Long-term, Disabling Psychiatric Disorders
4.8 Utility of Multiaxial Assessment in the Rehabilitative Work with Chronically Disturbed Patients
4.9 "Clanning" for Recovery
4.10 Stigma and Schizophrenia: The Greek Experience
4.11 Disability and Stigma Prevention: The Russian Experience
4.12 Are Western Models of Psychiatric Rehabilitation Feasible and Appropriate for Developing Countries?
4.13 Is Schizophrenia a Chronic Illness? The Experience of Developing Countries
4.14 Prevention of Disability and Stigma: Experience from a Developing Country
Ch. 5 Schizophrenia Spectrum Disorders
Schizophrenia Spectrum Disorders: A Review
5.1 Extending the Schizophrenia Spectrum even Further
5.2 Schizotypy: Theoretical Considerations, Latent Structure, and the Expanded Phenotype
5.3 Empirical Characterization of the Schizophrenia Spectrum
5.4 Exploring Schizophrenia Across the Continuum
5.5 Schizophrenia Spectrum Disorders and the Psychotic Continuum
5.6 Dimensions of Schizotypy in Symptomatic, Neurocognitive and Psychophysiological Indicators
5.7 The Role of Syndromes and Neurophysiology in Conceptualizing the Schizophrenia Spectrum and Predisposing Influences
5.8 Irremediable Flaws in the Schizophrenia Spectrum Concept
5.9 Do Not Dismiss the Single Major Locus Hypothesis So Quickly
5.10 Schizophrenia Spectrum: Where to Draw the Boundary?
5.11 Is There a Place for the Nature-Nurture Hypothesis in the Aetiology of Schizophrenia Spectrum Disorders?
5.12 Schizophrenia Spectrum - a "Terra Flexibilis"
5.13 Some Open Research Issues Concerning Schizophrenia Spectrum Disorders
5.14 Schizophrenia Spectrum Disorders Revisited
Ch. 6 Economics of Schizophrenia
Economics of Schizophrenia: A Review
6.1 Is Schizophrenia Worth the Cost?
6.2 Morality and Cost in the Management of Schizophrenia
6.3 Caveat Emptor: Pitfalls in Measuring the Costs of Schizophrenia
6.4 The Economic Consequences of Schizophrenia
6.5 The Many and the Few: Evidence-based Mental Health in a Primary-care-led Health Service
6.6 The Long-term Course of Schizophrenia and its Economic Consequences
6.7 Health Economics in Schizophrenia: Clouding or Clarifying?
6.8 The Economic Burden of Schizophrenia
6.9 Lack of Comprehensive Care for Schizophrenic Patients: Is it Due to Prohibitive Costs or Insufficient Advocacy?
6.10 The Role of Cost-effectiveness Analysis in Improving the Treatment of Schizophrenia
6.11 Medical Cost Outcomes of the Atypical Antipsychotics
6.12 The Costs of Schizophrenia - New Treatments and New Economics
Acknowledgements for the First Edition
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Terms of Use.
  • - Barnes & reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)